Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Version 57 was added on 2026-05-01, and the record now shows a QC status of Has Not Concluded. The history presents expanded content areas such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Eligibility, Arms and Interventions, Study Design, Study Description, Study Status, and related document sections.
    Difference
    1.0%
    Check dated 2026-05-08T23:10:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s build/release “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/software version bump rather than a change to the displayed trial record history content.
    Difference
    0.1%
    Check dated 2026-04-24T16:41:34.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The history now shows Results Submitted and Revision: v3.5.2, replacing No Results Posted and Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:29:12.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the history list.
    Difference
    0.1%
    Check dated 2026-03-19T19:22:42.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The new screenshot shows Revision: v3.4.3 in the history, replacing Revision: v3.4.2. This is a small metadata update documenting the latest version.
    Difference
    0.1%
    Check dated 2026-03-12T10:43:07.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The screenshots depict the same history page with only minor UI/organizational changes and a new version entry added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T18:32:34.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.